The U.S. Supreme Court is hearing arguments today in a case that could severely limit access to the abortion pill mifepristone, which is used for roughly two-thirds of all U.S. abortions. Last year, the 5th Circuit Court sided with a right-wing Texas judge who ruled the FDA improperly eased regulations on the pill to make it more accessible. The Supreme Court that overturned Roe v. Wade in 2022 will now decide whether to reverse the FDA measures, which made the pill available through the mail and via telemedicine. It could also roll back the FDA’s decision to lengthen the window within which mifepristone can be taken, which is now through 10 weeks of gestation.